Toshihiro Misumi

9PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacology and therapeuticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 25, 2025
Associations between early tumor shrinkage/depth of response and survival from the ARCAD database.

Hideaki Bando, Yuriko Takeda, Toshihiro Misumi

|Apr 16, 2025
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834.

Satoru Miura, Hiroshi Tanaka, Toshihiro Misumi

|Oct 11, 2024
Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.

Hidetoshi Hayashi, Makoto Nishio, Hiroaki Akamatsu

|Jan 02, 2024
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study).

Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi

|Oct 10, 2023
Trends in oncology drug lags in Japan from 2001 to 2020: A cross-sectional study.

Hideki Maeda, Asuka Hara, Momoka Ofuchi

|Dec 12, 2022
Prognosis of IPF patients with comorbid lung cancer: Preventing immortal time bias will make the analysis more valuable.

Sho Yamada, Satoshi Ikeda, Toshihiro Misumi

Pageof 2

Frequent Collaborators

4 joint publications

Satoshi Ikeda

4 joint publications

Naoki Furuya

4 joint publications

Satoru Miura

3 joint publications

Yuichi Takiguchi